Clinical Trials

Cannabinoids are certain chemical compounds found only in cannabis. Delta-9 tetrahydrocannabinol is (THC) is the most commonly recognized. This is what gives users that telltale euphoric feeling. THC may also play a role, should medical marijuana continue to become mainstream, as a painkiller. In fact, one study found that those states that passed a medical […]

by

Cannabinoids are certain chemical compounds found only in cannabis. Delta-9 tetrahydrocannabinol is (THC) is the most commonly recognized. This is what gives users that telltale euphoric feeling. THC may also play a role, should medical marijuana continue to become mainstream, as a painkiller. In fact, one study found that those states that passed a medical […]

by

SAN DIEGO, CA –(Marketwired – January 09, 2017) – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used […]

by

SAN DIEGO, CA –(Marketwired – January 09, 2017) – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used […]

by

SAN DIEGO, CA –(Marketwired – January 09, 2017) – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) has received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be […]

by

The registration with the European Cosmetics Products Notification Portal (CPNP) follows the successful completion of safety assessment, which included skin patch tests on 30 human volunteers. The development of a dermatologically tested cannabidiol skin care product range is a key priority for MGC, given the significant commercial opportunity that such products represents globally. The company […]

by

AXIM Biotechnologies (AXIM Biotech) cannabinoid research and development says it has received positive pharmacokinetic (PK) data results on its CanChew Plus CBD Gum. As a result, the company said it will start clinical trials on the gum for alleviating the symptoms of irritable bowel syndrome (IBS).  IBS patient trial Volunteers took part in a study […]

by

NEW YORK, January 5, 2017 /PRNewswire/ — http://www.Financialbuzz.com – Over the recent few years, particularly in 2016, the legal cannabis industry has accomplished some significant milestones. Most importantly is the change of public opinion regarding the use of cannabis, both for medical and recreational purposes. Before the November 8th elections where five states voted on […]

by

REDONDO BEACH, CA–(Marketwired – Jan 5, 2017) – SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an article discussing the recent, successful completion of AXIM® Biotechnologies’ ( OTCQB : AXIM ) pharmacokinetic (PK) study of its CanChew Plus® CBD Gum. The single-dose study on 10 mg […]

by

As a result of this election cycle, as five additional states voted in favor legalization, including California, the largest market for the industry, The Drug Enforcement Administration also changed its approach. The DEA has previously declined to reschedule cannabis under the Controlled Substances Act, has now made easier access for research, and upping the number […]

by

NEW YORK, Jan. 04, 2017 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, and gears up for clinical trial on alleviating the symptom of irritable bowel syndrome (IBS). The single dose study on 10 […]

by